Published in Hepatitis Weekly, January 27th, 2003
Results were reported for phase I clinical trials of Albuferon-alpha in adults with hepatitis C, and of BLyS in patients with common variable immunodeficiency (CVID). The company also discussed previously disclosed results of a phase I clinical trial of Albutropin in adults with growth hormone deficiency, and provided an update on the progress of other drugs in Human Genome Sciences' clinical development pipeline.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.